Head-to-head · WeighScore
Lean Rx vs LIV by WellNow
The verdict
LIV by WellNow takes it — 62.9/100 to 60.6/100.
LIV by WellNow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Lean Rx | LIV by WellNow |
|---|---|---|
| WeighScore | 60.6/100 | 62.9/100 |
| Grade | C | C |
| Scorecard rank | #319 | #265 |
| Semaglutide | $266/mo (starting dose, compounded) | $279/mo |
| Tirzepatide | $399/mo (starting dose, compounded) | Not disclosed |
| Coverage | Coverage not published | 5 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #319 · C
Strengths
- Both semaglutide and tirzepatide offered
- Three formulations: injectable, sublingual, and tablet
- Upfront pricing with no hidden fees advertised
- Semaglutide starts at a low $266/month
- Telehealth call with a licensed provider before prescribing
Where it loses points
- Compounded-only; no FDA-approved branded options
- No published state availability list
- Platform is technology only, not a healthcare provider itself
- Provider credentials not detailed on site
Graded #265 · C
Strengths
- Flat $279/month covers medication, supplies, and unlimited virtual visits
- Backed by established WellNow Urgent Care brand
- Board-certified online medical providers
- Same-day approval and monthly home delivery
- Transparent all-inclusive pricing with no hidden fees
Where it loses points
- Compounded semaglutide is not FDA-approved or evaluated
- Only available in five states (IL, IN, MI, NY, PA)
- No tirzepatide option offered
- Insurance not accepted for compounded semaglutide
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.